Wells Fargo’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-335
| Closed | -$831 | – | 7099 |
|
|
2025
Q2 | $831 | Sell |
335
-20,237
| -98% | -$39K | ﹤0.01% | 6327 |
|
|
2025
Q1 | $31.9K | Buy |
20,572
+453
| +2% | +$950 | ﹤0.01% | 5544 |
|
|
2024
Q4 | $43.1K | Buy |
20,119
+5,932
| +42% | +$17K | ﹤0.01% | 5534 |
|
|
2024
Q3 | $61.7K | Buy |
14,187
+469
| +3% | +$2.55K | ﹤0.01% | 5266 |
|
|
2024
Q2 | $63.9K | Buy |
13,718
+13,439
| +4,817% | +$72.1K | ﹤0.01% | 5192 |
|
|
2024
Q1 | $1.42K | Buy |
279
+5
| +2% | +$20 | ﹤0.01% | 6085 |
|
|
2023
Q4 | $770 | Sell |
274
-86
| -24% | -$202 | ﹤0.01% | 6289 |
|
|
2023
Q3 | $1.03K | Buy |
360
+113
| +46% | +$416 | ﹤0.01% | 6193 |
|
|
2023
Q2 | $1.25K | Sell |
247
-394
| -61% | -$805 | ﹤0.01% | 6281 |
|
|
2023
Q1 | $1.21K | Buy |
641
+402
| +168% | +$924 | ﹤0.01% | 6324 |
|
|
2022
Q4 | $430 | Sell |
239
-496
| -67% | -$893 | ﹤0.01% | 6425 |
|
|
2022
Q3 | $1K | Sell |
735
-16
| -2% | -$49 | ﹤0.01% | 6276 |
|
|
2022
Q2 | $1K | Sell |
751
-1,179
| -61% | -$2.74K | ﹤0.01% | 6462 |
|
|
2022
Q1 | $6K | Sell |
1,930
-8,075
| -81% | -$29.5K | ﹤0.01% | 6415 |
|
|
2021
Q4 | $53K | Sell |
10,005
-3,663
| -27% | -$25.6K | ﹤0.01% | 5944 |
|
|
2021
Q3 | $115K | Buy |
13,668
+289
| +2% | +$2.85K | ﹤0.01% | 5336 |
|
|
2021
Q2 | $163K | Sell |
13,379
-656,475
| -98% | -$13M | ﹤0.01% | 5113 |
|
|
2021
Q1 | $16.3M | Buy |
669,854
+6,221
| +0.9% | +$168K | ﹤0.01% | 1826 |
|
|
2020
Q4 | $21.3M | Buy |
663,633
+201,246
| +44% | +$6.61M | 0.01% | 1516 |
|
|
2020
Q3 | $14M | Buy |
462,387
+177,855
| +63% | +$5.41M | ﹤0.01% | 1666 |
|
|
2020
Q2 | $12M | Buy |
284,532
+266,336
| +1,464% | +$9.8M | ﹤0.01% | 1713 |
|
|
2020
Q1 | $454K | Buy |
+18,196
| New | +$554K | ﹤0.01% | 4108 |
|
Other funds holding BDTX
VPC
NMC
TCM
SL
